Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Analysis of a Topical Serum Comprised of Plant-based Adaptogens Developed to Support Homeostasis and Skin Quality. | J Clin Aesthet Dermatol | 2024 | 38444426 | PubTator, text mining | PubMed |
| Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX Models. | Cancer Genomics Proteomics | 2024 | 38423598 | PubTator, text mining | PubMed |
| Elucidating Hedgehog pathway's role in HNSCC progression: insights from a 6-gene signature. | Sci Rep | 2024 | 38409358 | PubTator, text mining | PubMed |
| Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38360074 | PubTator, text mining | PubMed |
| Water-soluble intracellular extract of Desmodesmus sp. YT enhanced the antioxidant capacity of human skin fibroblast to protect the skin from UV damage. | J Cosmet Dermatol | 2024 | 38327116 | PubTator, text mining | PubMed |
| Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors. | Toxicol Appl Pharmacol | 2024 | 38325586 | PubTator, text mining | PubMed |
| Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38308689 | PubTator, text mining | PubMed |
| Lipid metabolism-related genes are involved in the occurrence of asthma and regulate the immune microenvironment. | BMC Genomics | 2024 | 38297226 | PubTator, text mining | PubMed |
| Nanoparticles with intermediate hydrophobicity polarize macrophages to plaque-specific Mox phenotype via Nrf2 and HO-1 activation. | J Hazard Mater | 2024 | 38280324 | PubTator, text mining | PubMed |
| Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif. | Redox Biol | 2024 | 38277963 | PubTator, text mining | PubMed |
| Changes in Immune Response during Pig Gestation with a Focus on Cytokines. | Vet Sci | 2024 | 38275932 | PubTator, text mining | PubMed |
| Unraveling the complex dynamics of signaling molecules in cellular signal transduction. | PNAS Nexus | 2024 | 38274121 | PubTator, text mining | PubMed |
| GelMA/PEDOT:PSS Composite Conductive Hydrogel-Based Generation and Protection of Cochlear Hair Cells through Multiple Signaling Pathways. | Biomolecules | 2024 | 38254695 | PubTator, text mining | PubMed |
| Selenium Nanoparticles in Protecting the Brain from Stroke: Possible Signaling and Metabolic Mechanisms. | Nanomaterials (Basel) | 2024 | 38251125 | PubTator, text mining | PubMed |
| Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech. | Vaccines (Basel) | 2024 | 38250904 | PubTator, text mining | PubMed |
| Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2024 | 38250308 | PubTator, text mining | PubMed |
| The Role of Calcium and Iron Homeostasis in Parkinson's Disease. | Brain Sci | 2024 | 38248303 | PubTator, text mining | PubMed |
| PSMD12 promotes non-small cell lung cancer progression through activating the Nrf2/TrxR1 pathway. | Genes Genomics | 2024 | 38243044 | PubTator, text mining | PubMed |
| GC/MS and LC/MS serum metabolomic analysis of Chinese LN patients. | Sci Rep | 2024 | 38233574 | PubTator, text mining | PubMed |
| Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy. | Redox Biol | 2024 | 38232458 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=19